Peer Review History
| Original SubmissionApril 22, 2020 |
|---|
|
PONE-D-20-11644 Automatic identification of a stable QRST complex for non-invasive evaluation of human cardiac electrophysiology PLOS ONE Dear Dr. Bergfeldt, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please address comments indicated by the Reviewers and shorten the length of the manuscript . Please submit your revised manuscript by Aug 09 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Elena G. Tolkacheva, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In this manuscript, the authors describe a method for recording vectorcardiograms (VCG) in a population sample. The conclusion is that with a 5 minute recording period, 99% of subjects can have an adequate tracing produced. The introduction attempts to cover all the relevant history of the vectorcardiogram. It could be shortened; the first paragraph is duplicative as the prognosis of VCG is repeated in the 2nd paragraph. The first 2 sentences of the 2nd paragraph could be removed. Instead, it might be nice for the reader to get a brief introduction to how/why the VCG is different from the standard ECG. Methods: please elaborate on what is meant by “randomized fashion”. How were participants recruited? What was randomly assigned? Do the author mean to say that a random sample of people from the population were recruited? If so, how many were they drawn from, how was randomization performed, what were the power calculations to determine sample size, how many people elected to or declined to participate? The distribution of normal/abnormal findings on VCG sounds similar to my clinical practice, are there other population samples for prevalence of abnormal ECG that can be referenced for comparison? If the goal of this investigation is to demonstrate the usability of this technique, the discussion should be more focused on that aspect. Would recommend more attention be given to clinical application of this technique. For example, there are 6 pages of methods on the technique, how translatable are those methods to clinical practice? If the median time to acquire a VCG is 9 minutes (longer than the average face to face time for a patient and a physician in most office visits), how practical is it? Is the additional prognostic information worth the time/effort? Reviewer #2: This study aimed to apply a novel method for standardizing the window of analysis for vectorcardiography in a large sample of patients in an epidemiological study in Sweden. Vectorcardiography is based on analysis of 12-lead ECG or Frank VCG recording leads and employs vector-based analyses (i.e., magnitude and angle) of recorded electrical signals. Though not readily employed clinically, the potential of VCG is convincingly great. This specific study in this space was unique, innovative, and largely technically appropriate. The authors demonstrated success of their algorithm in comparison to a randomly selected and manually annotated vectorcardiogram, success in delineating differences between men and women that they saw in their demographic analysis, consistency in serial visits with the same patient, and success in consistently producing a stable signal-averaged QRS complex and T wave for analysis with standard VCG tools. Additionally, the authors recognized the limitations of their study and drew mostly appropriate conclusions from their results. However, there is a major concern about the motivation and significance of this research. The authors did not fully elucidate the need for such an algorithm nor did they convincingly demonstrate how the application of their algorithm will aid in clinical care. These issues and some technical issues listed below should be considered before acceptance: Major Comments • Introduction 1. Greater discussion on the application of VCG in clinical scenarios, uniqueness compared to ECG (i.e., what complementary or supplementary information is given by the VCG), and prognostic value need to be established. These are vaguely described in Lines 87-100, but a clear description of VCG, its parameters, and its merits/disadvantages need to be included, especially given its nonstandard use. A diagram explaining VCG would be helpful, though not necessary as there are various other sources that the authors include for this. Additionally, the problem with manual selection of VCG segments must be delineated. Without these descriptions of VCG, the significance, novelty, and innovation of the authors’ study is lost. • Methods 1. If it is possible to do, the variability between multiple observers (at least two) in manually edited annotation points is an important parameter to include to help demonstrate the success of your automatic algorithm. 2. What is the importance of the instability value and how do you actually calculate it? You discuss that the variability value is calculated from averaging the difference between the fixed and alignment waveforms, and that values of difference greater than 5 uV are used to calculate the instability value, but the actual calculation of instability is unclear. Additionally, the physiologic importance is not well established other than vaguely in Table 5 where “external disturbances” and “internal variations” are mentioned as contributing factors to instability. The process of manually defining something as “external” or “internal” is suspect without a more complete and rigorous analysis. Please describe how you delineated this. • Results 1. The significance of a percentage difference in CV in Table 3 is unclear. Though a larger difference in CV would show that there is greater variability in the manual annotation on the fourth saQRST than in your automated algorithm, the significance of a 11.7% vs. 14.7 % difference is unclear. An interpretation or a separate statistic that indicates significant differences would be helpful. Additionally, it is assumed that there will be some inter-beat variability regardless of whether the automated or manual technique is used. Is part of the CV difference due to this inter-beat variability? 2. As discussed in Methods Comment 2, the reasoning behind classifying an instability value as due to external disturbances or internal sources of variability is essential. Is there a way to demonstrate what each of these would look like in a representative trace? Or are there criteria that your VCG reader used to define this? • Discussion 1. One of the major questions that remains despite the success of your algorithm/study is the applicability of this technique. First, as you note in the paper, the typical ECG/VCG protocol does not include 5-10 minutes of recording so using this algorithm seems to potentially be impractical/infeasible. Second, because you chose not to look at how specifically the algorithm did in those with underlying heart disease (especially arrhythmias), the importance and utility of the algorithm is unclear. This is especially true as the VCG is expected to help diagnose transient arrhythmias like AF. As such, the success of the algorithm to identify a stable region of the VCG in these conditions is important, and I am not convinced that the author’s algorithm is capable of accomplishing this. Minor Comments • Abstract 1. QRST complex is not a standard complex according to typical ECG where there is a QRS complex and a T wave. Consider defining this complex in the abstract so the reader understands. • Methods 1. Why was the second visit non-standardized? Would this have an effect on secondary results? 2. Where on the neck and back are electrodes placed? It would be helpful to include anatomical landmarks nearby like the vertebrae, vasculature, etc. 3. What is a signal-averaged QRST complex? Some specifics on this calculation would be helpful as it is hard to understand how 70 seconds could represent 7 10s-saQRST complexes and the order of operations that produces a signal averaged complex is unclear. Additionally, is this averaging the same or different than the process you describe for selecting the representative complex? 4. Can you explain why a sliding absolute difference between a portion of the QRS complex was used rather than a cross-correlation for the alignment steps? 5. Was there a reason that 5 uV was selected as the threshold to add to the instability value? 6. A quick question regarding the annotation. It is clear that the algorithm in this paper is focused on selection of a standard window for analysis of VCG parameters. However, the automatic/manual annotation of these parameters is not clear. Can you describe briefly how these parameters are selected and how sensitive the process is to noise? Perhaps using Supplemental Figure 1. • Results 1. Table 1 is an excellent representation of demographics and shows clear differences in biological sex and various parameters in the study. Additionally, Table 2 excellently portrays the difference in various VCG parameters between men and women. A tertiary analysis of other demographics and VCG parameters seems warranted (especially since the data is available). 2. What were the values of the Shapiro Wilk test for normality and how did you decide to accept the null hypothesis (i.e., what value of the Shapiro Wilk test was used for this)? Qualitatively, there appears to be a relatively normal spread so more clarity would be appreciated. 3. Is there a statistic to effectively compare the CV, mean, or s.d. of the two different annotations in Table 4? If so, this information would be useful to the reader to understand the significance of this automated annotation. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Automatic identification of a stable QRST complex for non-invasive evaluation of human cardiac electrophysiology PONE-D-20-11644R1 Dear Dr. Bergfeldt, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Elena G. Tolkacheva, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: All comments have been adequately addressed, and there are no new concerns. The manuscript should be accepted for publication. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No |
| Formally Accepted |
|
PONE-D-20-11644R1 Automatic identification of a stable QRST complex for non-invasive evaluation of human cardiac electrophysiology Dear Dr. Bergfeldt: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Elena G. Tolkacheva Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .